No Data
No Data
Shareholders In Shanghai MicroPort Endovascular MedTech (SHSE:688016) Should Look Beyond Earnings For The Full Story
shanghai microport endovascular medtech(group)co.,ltd. (688016.SH): In October, the company did not repurchase A-shares through centralized auction trading.
On November 4th, Ge Longhui reported that shanghai microport endovascular medtech(group)co.,ltd. (688016.SH) announced that in October 2024, the company did not repurchase A-shares through centralized bidding trading. As of October 31, 2024, the company has repurchased a total of 894,027 shares through the Shanghai Stock Exchange exchange trading system by centralized bidding trading method, accounting for 0.73% of the company's total share capital of 123,262,117 shares. The highest price for repurchase was 98.13 yuan/share, the lowest price was 78.69 yuan/share, and the total amount paid was RMB 79,989,242.97 (excluding prin
Shanghai MicroPort Endovascular MedTech Co., Ltd. Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
shanghai microport endovascular medtech(group)co.,ltd. (688016.SH) announced a half-year equity distribution for 2024: a dividend of 1.66205 yuan per share, with the record date of November 7th.
shanghai microport endovascular medtech(group)co.,ltd. (688016.SH) issued the 2024 interim equity distribution announcement to implement the 2024 interim...
Cardiac Healthcare: third quarter report 2024
shanghai microport endovascular medtech(group)co.,ltd. (688016.SH): net income in the first three quarters was 0.553 billion yuan, a year-on-year increase of 42.46%.
GeLongHui October 29th | shanghai microport endovascular medtech(group)co.,ltd. (688016.SH) announced its third-quarter report, with a revenue of 0.97 billion yuan in the first three quarters, a year-on-year increase of 9.13%, a net income of 0.553 billion yuan, a year-on-year increase of 42.46%, a non-GAAP net income of 0.5 billion yuan, a year-on-year increase of 37.37%, and basic earnings per share of 4.49 yuan.
No Data
No Data